REC-994
REC-994 Uses, Dosage, Side Effects, Food Interaction and all others data.
REC-994 was cleared by the FDA in July, 2018 for a phase I trial for the treatment of cerebral cavernous malformation (CCM).
| Trade Name | REC-994 |
| Generic | REC-994 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here REC-994
